ATE110958T1 - Verwendung von sertralin zur behandlung verfrühter ejakulation. - Google Patents

Verwendung von sertralin zur behandlung verfrühter ejakulation.

Info

Publication number: ATE110958T1
Authority: AT; Austria
Prior art keywords: sertraline; premature ejaculation; treat premature; ejaculation; treat
Prior art date: 1989-08-30

Application number

AT90309063T

Other languages

English (en)

Inventor

Peter A Bick

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-30

Filing date

1990-08-17

Publication date

1994-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23583530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE110958(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-08-17 Application filed by Pfizer filed Critical Pfizer

1994-09-15 Application granted granted Critical

1994-09-15 Publication of ATE110958T1 publication Critical patent/ATE110958T1/de

Links

206010036596 premature ejaculation Diseases 0.000 title abstract 2
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2
229960002073 sertraline Drugs 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT90309063T 1989-08-30 1990-08-17 Verwendung von sertralin zur behandlung verfrühter ejakulation. ATE110958T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/400,417 US4940731A (en)	1989-08-30	1989-08-30	Method of treating premature ejaculation using sertraline

Publications (1)

Publication Number	Publication Date
ATE110958T1 true ATE110958T1 (de)	1994-09-15

Family

ID=23583530

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90309063T ATE110958T1 (de)	1989-08-30	1990-08-17	Verwendung von sertralin zur behandlung verfrühter ejakulation.

Country Status (19)

Country	Link
US (1)	US4940731A (de)
EP (1)	EP0415613B1 (de)
JP (1)	JPH0393718A (de)
KR (1)	KR910004187A (de)
AT (1)	ATE110958T1 (de)
AU (1)	AU609664B1 (de)
CA (1)	CA2024188C (de)
CY (1)	CY1973A (de)
DE (1)	DE69012261T2 (de)
DK (1)	DK0415613T3 (de)
HK (1)	HK219196A (de)
HU (1)	HU213474B (de)
IE (1)	IE63470B1 (de)
IL (1)	IL95473A (de)
MY (1)	MY106938A (de)
NZ (1)	NZ235101A (de)
PH (1)	PH26998A (de)
PT (1)	PT95117B (de)
ZA (1)	ZA906883B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR0148511B1 (ko) *	1993-09-14	1998-11-02	최형기	성신경과민증 예방 및 치료용 의약조성물
US5597826A (en)	1994-09-14	1997-01-28	Pfizer Inc.	Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US20040208926A1 (en) *	1997-07-01	2004-10-21	Pfizer Inc	Solubilized sertraline compositions
US20030133974A1 (en) *	1997-07-01	2003-07-17	Curatolo William John	Encapsulated solution dosage forms of sertraline
IL133080A0 (en)	1997-07-01	2001-03-19	Pfizer	Sertraline salts and sustained-release dosage forms of sertraline
US6403597B1 (en)	1997-10-28	2002-06-11	Vivus, Inc.	Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6228864B1 (en)	1997-10-28	2001-05-08	Vivus, Inc.	Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US5922341A (en) *	1997-10-28	1999-07-13	Vivus, Incorporated	Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) *	1997-10-28	2000-03-14	Vivus, Incorporated	Administration of 5-HT3 receptor antagonists to treat premature ejaculation
UA72743C2 (en) *	1998-10-13	2005-04-15	Pfizer Prod Inc	Essentially nonaqueous liquid pharmaceutical concentrate composition containing sertraline, method of using this concentrate, method for treatment
IL132500A0 (en)	1998-10-29	2001-03-19	Pfizer Prod Inc	Stereoselective microbial reduction of a racemic tetralone
ES2245639T3 (es) *	1999-03-01	2006-01-16	Pfizer Inc.	Compuestos 1,2,3,4-tetrahidro-1-naftalenamina utiles en terapia.
US6245782B1 (en)	1999-05-17	2001-06-12	Heartdrug Research L.L.C.	Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
EP1671628B1 (de) *	1999-09-03	2012-10-03	APBI Holdings, LLC	Selektive Serotonin-Aufnahme Inhibitoren mit schnellem Wirkungseintritt zur Behandlung von sexueller Dysfunktionen
WO2001047498A2 (en)	1999-12-23	2001-07-05	Pfizer Products Inc.	Hydrogel-driven layered drug dosage form comprising sertraline
GB0007884D0 (en) *	2000-03-31	2000-05-17	Pfizer Ltd	Diphenyl ether compounds useful in therapy
US6448293B1 (en)	2000-03-31	2002-09-10	Pfizer Inc.	Diphenyl ether compounds useful in therapy
CN1091096C (zh) *	2000-09-15	2002-09-18	哈尔滨健迪医药科技开发有限公司	舍曲林柠檬酸盐及其用于治疗哺乳动物早泄的用途
US6495154B1 (en)	2000-11-21	2002-12-17	Vivus Inc.	On demand administration of clomipramine and salts thereof to treat premature ejaculation
NZ528935A (en)	2001-03-16	2004-10-29	Dmi Biosciences Inc	Method of delaying ejaculation
US20040131672A1 (en) *	2003-01-07	2004-07-08	Nilobon Podhipleux	Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
AU2003903597A0 (en) *	2003-07-11	2003-07-24	Jakov Vaisman	Treatment of premature ejaculation
EP1737473A4 (de) *	2004-04-19	2009-08-26	Noven Therapeutics Llc	Lithium-kombinationen und relevante verwendungen
BRPI0509592A (pt) *	2004-05-06	2007-09-25	Cydex Inc	formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila
EP1969117A4 (de) *	2005-12-13	2008-12-17	Trinity Lab Inc	Verfahren zur behandlung einer vorzeitigen ejakulation beim menschen
US7893053B2 (en)	2006-06-16	2011-02-22	Theracos, Inc.	Treating psychological conditions using muscarinic receptor M1 antagonists
US20090005319A1 (en) *	2007-07-01	2009-01-01	Barone Jr Frank V	Topical compositions for delaying ejaculation and methods of using the same
US9272671B2 (en)	2013-06-28	2016-03-01	Faurecia Interior Systems, Inc.	Display screen arrangement and method of assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4029731A (en) *	1974-11-06	1977-06-14	Pfizer Inc.	Aminophenyltetralin compounds
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4507323A (en) *	1984-07-25	1985-03-26	Burroughs Wellcome Co.	Treatment of psychosexual dysfunctions
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline

1989
- 1989-08-30 US US07/400,417 patent/US4940731A/en not_active Expired - Lifetime
1990
- 1990-08-17 DK DK90309063.7T patent/DK0415613T3/da active
- 1990-08-17 DE DE69012261T patent/DE69012261T2/de not_active Expired - Fee Related
- 1990-08-17 EP EP90309063A patent/EP0415613B1/de not_active Expired - Lifetime
- 1990-08-17 AT AT90309063T patent/ATE110958T1/de not_active IP Right Cessation
- 1990-08-21 PH PH41056A patent/PH26998A/en unknown
- 1990-08-23 IL IL9547390A patent/IL95473A/en not_active IP Right Cessation
- 1990-08-28 CA CA002024188A patent/CA2024188C/en not_active Expired - Fee Related
- 1990-08-28 PT PT95117A patent/PT95117B/pt not_active IP Right Cessation
- 1990-08-28 MY MYPI90001472A patent/MY106938A/en unknown
- 1990-08-29 KR KR1019900013368A patent/KR910004187A/ko not_active Ceased
- 1990-08-29 HU HU905682A patent/HU213474B/hu not_active IP Right Cessation
- 1990-08-29 AU AU61944/90A patent/AU609664B1/en not_active Ceased
- 1990-08-29 IE IE312390A patent/IE63470B1/en not_active IP Right Cessation
- 1990-08-29 ZA ZA906883A patent/ZA906883B/xx unknown
- 1990-08-30 JP JP2229545A patent/JPH0393718A/ja active Pending
- 1990-08-30 NZ NZ235101A patent/NZ235101A/en unknown
1996
- 1996-12-24 HK HK219196A patent/HK219196A/en not_active IP Right Cessation
1997
- 1997-09-05 CY CY197397A patent/CY1973A/xx unknown

Also Published As

Publication number	Publication date
HU905682D0 (en)	1991-03-28
HK219196A (en)	1997-01-03
DE69012261T2 (de)	1995-01-12
EP0415613A3 (en)	1992-02-26
NZ235101A (en)	1997-01-29
HUT58512A (en)	1992-03-30
HU213474B (en)	1997-06-30
CA2024188C (en)	1994-11-08
DE69012261D1 (de)	1994-10-13
IL95473A (en)	1995-08-31
EP0415613A2 (de)	1991-03-06
KR910004187A (ko)	1991-03-28
DK0415613T3 (da)	1994-10-10
PT95117B (pt)	1997-05-28
EP0415613B1 (de)	1994-09-07
ZA906883B (en)	1992-04-29
US4940731A (en)	1990-07-10
CA2024188A1 (en)	1991-03-01
PT95117A (pt)	1991-05-22
AU609664B1 (en)	1991-05-02
IE63470B1 (en)	1995-04-19
IE903123A1 (en)	1991-03-13
JPH0393718A (ja)	1991-04-18
MY106938A (en)	1995-08-30
PH26998A (en)	1993-02-01
CY1973A (en)	1997-09-05

Legal Events

Date	Code	Title	Description
1995-03-15	UEP	Publication of translation of european patent specification
2006-05-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69012261D1 (de)	1994-10-13	Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
MY106075A (en)	1995-03-31	A method of treating anxiety-related disorders using sertraline.
DE69434431D1 (de)	2005-08-25	Methoden zur behandlung von muskelerkrankungen und muskelstörungen
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69616376D1 (de)	2001-11-29	Verwendung von Tiagabin zur Behandlung von Schlafstörungen
NZ504026A (en)	2002-12-20	Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE69526937D1 (de)	2002-07-11	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE137965T1 (de)	1996-06-15	Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DE69800859D1 (de)	2001-07-05	Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
ATE281841T1 (de)	2004-11-15	Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE235237T1 (de)	2003-04-15	Sertralin zur behandlung von post-myocard-infarkt-patienten
DE69004529D1 (de)	1993-12-16	Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ATE204476T1 (de)	2001-09-15	Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE69424679D1 (de)	2000-06-29	Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69428797D1 (de)	2001-11-29	Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
DE69307702D1 (de)	1997-03-06	Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit